GGrantIndex
← Search

AEROSOLIZED INTERFERON G IN MULTIDRUG RESISTANT TUBERCULOSIS

$21,006M01FY2000RRNIH

New York University School Of Medicine, New York NY

Investigators

Linked publications & trials

Abstract

This Phase II crossover study attempts to investigate the safety and efficacy of aerosolized Interferon-g for the treatment of pulmonary multidrug resistant tuberculosis. The primary endpoint is time to conversion of sputum AFB smear to negative. Secondary endpoints are time to grow M. tuberculosis in culture, CT findings, constitutional symptoms, conversion of sputum culture to negative and the time of conversion of sputum culture to negative.

View original record on NIH RePORTER →